Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Cheap Valuation

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Jan 31, 2023 6:41pm

158 Views

Post# 35258168

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Cheap Valuation

gudisgood ...

My last message was not directed at you but more of a general statement. I think many get lost in their anger and they really only have themselves to blame. You can see who doesn't want to take blame.

-------

For GUD ... there is only one important number (assuming growth /cashflow continue to be strong - but - there will be pauses too as teh company comes up for air at times).

The important number is at AGM voting - how many people attend the voting and what percentage of the shares they represent. That really is the key number here and it tells a lot.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023